bodymilk copenhagen ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2018
N/A
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  0.0% 10.4% 9.1% 6.5% 7.7%  
Credit score (0-100)  0 25 27 35 31  
Credit rating  N/A BB BB BBB BB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2018
N/A
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12

Net sales  0 0 0 0 0  
Gross profit  0.0 9.2 303 328 372  
EBITDA  0.0 9.2 159 126 64.5  
EBIT  0.0 9.2 159 126 64.5  
Pre-tax profit (PTP)  0.0 9.2 155.1 123.1 61.7  
Net earnings  0.0 7.1 118.2 95.6 47.5  
Pre-tax profit without non-rec. items  0.0 9.2 155 123 61.7  

 
See the entire income statement

Balance sheet (kDKK) 
2018
N/A
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12

Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  0.0 7.1 125 221 268  
Interest-bearing liabilities  0.0 6.0 0.0 0.0 0.0  
Balance sheet total (assets)  0.0 18.1 372 394 342  

Net Debt  0.0 -2.7 -247 -266 -193  
 
See the entire balance sheet

Volume 
2018
N/A
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  0.0 9.2 303 328 372  
Gross profit growth  0.0% 0.0% 3,190.3% 8.6% 13.3%  
Employees  0 1 1 1 1  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  0 18 372 394 342  
Balance sheet change%  0.0% 0.0% 1,951.6% 5.9% -13.1%  
Added value  0.0 9.2 158.5 126.4 64.5  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 0 0  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  0.0 1.0 2.0 3.0 4.0  

Profitability 
2018
N/A
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  0.0% 100.0% 52.4% 38.5% 17.3%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  0.0% 50.7% 81.3% 33.0% 17.5%  
ROI %  0.0% 70.2% 229.1% 73.0% 26.4%  
ROE %  0.0% 100.0% 178.6% 55.2% 19.4%  

Solidity 
2018
N/A
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
Equity ratio %  0.0% 39.1% 33.7% 56.1% 78.4%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  0.0% -29.6% -155.8% -210.7% -298.6%  
Gearing %  0.0% 84.6% 0.0% 0.0% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.3% 113.9% 0.0% 0.0%  

Liquidity 
2018
N/A
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
Quick Ratio  0.0 1.6 1.5 2.3 4.6  
Current Ratio  0.0 1.6 1.5 2.3 4.6  
Cash and cash equivalent  0.0 8.7 247.0 266.3 192.7  

Capital use efficiency 
2018
N/A
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  0.0 7.1 125.3 220.9 268.4  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2018
N/A
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 9 159 126 65  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 9 159 126 65  
EBIT / employee  0 9 159 126 65  
Net earnings / employee  0 7 118 96 48